RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 78-88
  • Allergan to slash workforce by 1,500

    Allergan to slash workforce by 1,500
    Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival. Stung by criticism that it'...
  • Allergan urges shareholders to reject Valeant buyout offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. said last week that it will take its acquisition offer directly to...
  • Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
  • Abbott to buy Russian drug maker

    Abbott to buy Russian drug maker
    Abbott Laboratories said Monday it has agreed to acquire a Russian pharmaceutical manufacturer for between $395 million and $495 million in cash plus the assumption of about $136 million in debt. The Lake County-based medical products company will...
  • AbbVie takes fight for Irish drugmaker to shareholders

    AbbVie Inc. on Wednesday took its fight for control of the Irish drugmaker Shire Plc directly to shareholders, calling for immediate talks for a transaction it views as "highly executable." The North Chicago-based pharmaceutical firm, know for its...
  • U.S. senators seek review of proposed Valeant buyout of Allergan

    Seven U.S. senators have asked the Justice Department and Federal Trade Commission to review the proposed acquisition of Botox maker Allergan Inc. by a Canadian company, saying the deal could increase consumer pricing and curtail the development of new...
  • Inhaled insulin drug Afrezza, from L.A.'s MannKind, is approved

    Inhaled insulin drug Afrezza, from L.A.'s MannKind, is approved
    Los Angeles billionaire inventor Alfred Mann's almost decade-long quest to develop an inhalable form of insulin for diabetics won approval Friday from U.S. regulators. His Valencia company, MannKind Corp., got the OK to sell the drug called Afrezza,...
  • Maryland overdose deaths jump

    Maryland overdose deaths jump
    An alarming spike in heroin and other drug overdose deaths in Maryland has prompted what the state's health secretary calls an "all hands on deck" effort to investigate and treat addiction. The number of drug- and alcohol-related deaths in Maryland...
  • U.S. regulator approves Afrezza inhalable insulin

    U.S. regulator approves Afrezza inhalable insulin
    After more than a decade of work and nearly $1 billion of his personal fortune, Los Angeles inventor Alfred Mann's quest to develop an inhalable form of insulin for people with diabetes won approval Friday from U.S. regulators. His company, MannKind...
  • MannKind shares rise 10% after insulin drug Afrezza OKd by FDA

    MannKind Corp., the Valencia company that last week won approval to market an inhalable form of insulin to people with diabetes, saw its shares climb 10% on Monday. The Food and Drug Administration announced Friday that it had approved MannKind's drug,...
  • AbbVie forced to retract claims of Shire investor support

    AbbVie forced to retract claims of Shire investor support
    AbbVie Inc. CEO Richard Gonzalez has landed in a bit of hot water for statements he made to certain newswires and U.K. press on Tuesday regarding shareholder support for his company's takeover bid for Shire Plc. The North Chicago-based pharmaceutical...